Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Gardner

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of the International AIDS Society|June 29, 2019
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START studyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
Annals of Emergency Medicine|April 25, 2024
Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments TrialJason Haukoos, Emily Hopkins, Jonathan D Campbell, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed TherapyPeter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with menSharon M Seifert, David V Glidden, Amie L Meditz, et al.
Trials|January 28, 2023
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis CSarah E Rowan, Jason Haukoos, Kevin F Kamis, et al.
JAMA|July 9, 2025
Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical TrialJason Haukoos, Richard E Rothman, James W Galbraith, et al.
The Journal of Infectious Diseases|July 10, 2020
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender SpectrumLaura M Smeaton, Emma M Kileel, Beatriz Grinsztejn, et al.
Trials|April 26, 2022
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departmentsJason S Haukoos, Sarah E Rowan, James W Galbraith, et al.
AIDS Research and Human Retroviruses|August 17, 2016
Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady StateSharon M Seifert, Xinhui Chen, Amie L Meditz, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of the International AIDS Society|June 29, 2019
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START studyJose R Castillo-Mancilla, Andrew N Phillips, James D Neaton, et al.
Annals of Emergency Medicine|April 25, 2024
Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments TrialJason Haukoos, Emily Hopkins, Jonathan D Campbell, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed TherapyPeter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent DosingJose Castillo-Mancilla, Sharon Seifert, Kayla Campbell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with menSharon M Seifert, David V Glidden, Amie L Meditz, et al.
Trials|January 28, 2023
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis CSarah E Rowan, Jason Haukoos, Kevin F Kamis, et al.
JAMA|July 9, 2025
Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical TrialJason Haukoos, Richard E Rothman, James W Galbraith, et al.
The Journal of Infectious Diseases|July 10, 2020
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender SpectrumLaura M Smeaton, Emma M Kileel, Beatriz Grinsztejn, et al.
Trials|April 26, 2022
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departmentsJason S Haukoos, Sarah E Rowan, James W Galbraith, et al.
AIDS Research and Human Retroviruses|August 17, 2016
Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady StateSharon M Seifert, Xinhui Chen, Amie L Meditz, et al.
Pageof 8